CS
TARO

Credit Suisse’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Credit Suisse’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$556K Hold
13,127
– – ﹤0.01% 2590
2023
Q4 		$548K Buy
13,127
+1,494
+13% +$55.1K ﹤0.01% 2685
2023
Q3 		$439K Sell
11,633
-502
-4% -$18.8K ﹤0.01% 2739
2023
Q2 		$460K Sell
12,135
-3,224
-21% -$101K ﹤0.01% 2825
2023
Q1 		$374K Sell
15,359
-28
-0.2% -$817 ﹤0.01% 2907
2022
Q4 		$447K Buy
15,387
+717
+5% +$21.3K ﹤0.01% 2855
2022
Q3 		$440K Buy
14,670
+805
+6% +$27.8K ﹤0.01% 2863
2022
Q2 		$501K Sell
13,865
-921
-6% -$35.1K ﹤0.01% 2833
2022
Q1 		$639K Buy
14,786
+629
+4% +$29.4K ﹤0.01% 2830
2021
Q4 		$709K Sell
14,157
-835
-6% -$46.8K ﹤0.01% 3578
2021
Q3 		$954K Buy
14,992
+9
+0.1% +$623 ﹤0.01% 3383
2021
Q2 		$1.08M Sell
14,983
-3,941
-21% -$289K ﹤0.01% 3323
2021
Q1 		$1.4M Buy
18,924
+291
+2% +$22.1K ﹤0.01% 3075
2020
Q4 		$1.37M Buy
+18,633
New +$1.2M ﹤0.01% 3106
2020
Q2 		– Sell
-4,845
Closed -$296K – 4178
2020
Q1 		$296K Buy
+4,845
New +$359K ﹤0.01% 3438
2019
Q3 		– Sell
-2,366
Closed -$203K – 4296
2019
Q2 		$203K Buy
2,366
+415
+21% +$41K ﹤0.01% 3835
2019
Q1 		$211K Buy
+1,951
New +$194K ﹤0.01% 3746
2018
Q4 		– Sell
-3,942
Closed -$388K – 4043
2018
Q3 		$388K Sell
3,942
-2,296
-37% -$248K ﹤0.01% 3425
2018
Q2 		$721K Buy
+6,238
New +$685K ﹤0.01% 3239
2018
Q1 		– Sell
-9,725
Closed -$1.02M – 4185
2017
Q4 		$1.02M Sell
9,725
-5,946
-38% -$653K ﹤0.01% 2980
2017
Q3 		$1.77M Buy
15,671
+752
+5% +$81.8K ﹤0.01% 2654
2017
Q2 		$1.67M Sell
14,919
-3,623
-20% -$409K ﹤0.01% 2344
2017
Q1 		$2.16M Buy
18,542
+410
+2% +$45.4K ﹤0.01% 2287
2016
Q4 		$1.91M Sell
18,132
-14,148
-44% -$1.48M ﹤0.01% 2477
2016
Q3 		$3.57M Buy
32,280
+15,698
+95% +$2.08M ﹤0.01% 1913
2016
Q2 		$2.42M Buy
16,582
+1,353
+9% +$192K ﹤0.01% 2193
2016
Q1 		$2.18M Sell
15,229
-2,089
-12% -$297K ﹤0.01% 2138
2015
Q4 		$2.68M Buy
17,318
+8,764
+102% +$1.28M ﹤0.01% 2072
2015
Q3 		$1.22M Sell
8,554
-10,223
-54% -$1.43M ﹤0.01% 2648
2015
Q2 		$2.7M Sell
18,777
-31,276
-62% -$4.46M ﹤0.01% 2302
2015
Q1 		$7.06M Buy
50,053
+18,054
+56% +$2.78M 0.01% 1423
2014
Q4 		$4.74M Sell
31,999
-15,850
-33% -$2.33M ﹤0.01% 1801
2014
Q3 		$7.36M Buy
47,849
+42,425
+782% +$6.39M 0.01% 1486
2014
Q2 		$761K Buy
5,424
+518
+11% +$57.5K ﹤0.01% 3528
2014
Q1 		$545K Sell
4,906
-2,195
-31% -$239K ﹤0.01% 3646
2013
Q4 		$702K Buy
7,101
+1,492
+27% +$129K ﹤0.01% 3544
2013
Q3 		$426K Buy
+5,609
New +$364K ﹤0.01% 3591

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Credit Suisse's TARO Position: Q1 2024 in Review

Credit Suisse held its Taro Pharmaceutical Industries Ltd. (TARO) position steady in Q1 2024 at 13,127 shares worth $556K. The position accounts for ﹤0.01% of the portfolio, ranked #2590.

Credit Suisse first reported a position in TARO in Q3 2013 and has held it in 37 quarters since. The position peaked at $7.36M in Q3 2014. 94 funds tracked by Wall St. Rank hold TARO as of Q1 2024.

  • Credit Suisse held 13,127 shares of Taro Pharmaceutical Industries Ltd. worth $556K as of Q1 2024.
  • Credit Suisse left its Taro Pharmaceutical Industries Ltd. share count unchanged in Q1 2024.
  • Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2590 holding.
  • Credit Suisse first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2013 and has held it in 37 quarters since.
  • Credit Suisse's Taro Pharmaceutical Industries Ltd. position peaked at $7.36M in Q3 2014.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.